The research of apoptosis in mononuclear lymphocytes of peripheral blood and tumor cells at patients with glial brain tumors
DOI:
https://doi.org/10.25305/unj.108634Keywords:
apoptosis, mononuclear lymphocytes of peripheral blood, gliomas, medulloblastomasAbstract
The purpose of our research was apoptosis study in mononuclear lymphocytes of peripheral blood (MNLPB) and tumor samples from patients with intracranial brain tumors. Patients with glial tumors comparing with healthy persons demonstrated increased quantity of lymphocytes in state of apoptotic. Hoechst33342+ and CD95+ cell amount in MNLPB of patients with gliomas decreased as the anaplasia degree of glioma grew, so as РІ+ cell level that determine irreversible apoptosis, increased as anaplasia degree of glioma grew, that may reflect different suppressors influence on lymphocytes in dependence of the tumor anaplasia degree. In gliomas of the IV anaplasia degree comparing to gliomas of II and III anaplasia degrees, the cells quantity in terminal stage of apoptosis (РІ+) was minimal, quantity of CD95+ cells, carrying receptor for apoptosis readiness was also minimal, the level of cells at early, reversible stages of apoptosis was meddle (Hoechst33342+). The РІ+ cells quantity decreased as anaplasia degree of glioma grew. In MNLPB of patients with medulloblastomas the level of readiness for apoptosis, convertible and irreversible lesions increased, that was conditioned by molecular-genetic features of these tumors.
References
Белушкина Н.Н., Северин С.Е. Молекулярные основы патологии апоптоза // Арх. патологии. — 2001. — Т.63, №1. — С.51–60.
Бережная Н.М. Роль клеток системы иммунитета в микроокружении опухоли. Клетки и цитокины — участники воспаления // Онкология. — 2009. — Т.11, №1. — С.6–16.
Бережная Н.М., Чехун В.Ф. Система иммунитета и рак: достижения и неудачи // Онкология. — 2003. — Т.5, №2. — С.84–89.
Бережная Н.М., Чехун В.Ф. Иммунология злокачественного роста. — К.: Наук. думка, 2005. — 791 с.
Лисяный Н.И., Любич Л.Д., Скитяк С.А., Гнедкова И.А. Исследование интенсивности апоптоза лимфоцитов периферической крови больных с глиомами и его корреляции с системой ИЛ-2 и ИФН- // Імунологія та алергологія. — 2003. — №4. — С.25–30.
Малишева Т.А., Черненко О.Г., Шамаєв М.І. Проліферативна активність і апоптоз в нейроектодермальних пухлинах // Матеріали IV з’їзду нейрохірургів України — Дніпропетровськ, 2008. — С.209–210.
Мамонтова Т.В., Кайдашев І.П. Спонтанний апоптоз та експресія білків bcl-2 та Р53 мононуклеарних клітин периферичної крові у хворих на атопічну бронхіальну астму // Імунологія та алергологія. — 2005. — №3. — С.43–46.
Пальцев М.А., Демура С.А., Коган Е.А. и др. Мелкоклеточный рак и карциномы легких: морфология апоптоза и экспрессия биомолекулярных маркеров опухолевого роста // Арх. патологии. — 2000. —Т.62, №5. — С.11–17.
Применение проточной цитометрии для оценки функциональной активности иммунной системы человека : Пособие для врачей-лаборантов / Сост.: Б.В. Пинегин и др. — М., 2001. — С.48–53.
Циклаури М.В., Гогебашвили Н.В. Нарушение функции иммунной системы и апоптоз лимфоцитов при травме, осложненной стафилококком // Імунологія та алергологія. — 2003. — №4. — С.37–38.
Чумаков В.А., Качков И.А., Захаров А.В. и др. Иммунодефицитные состояния при глиальных опухолях головного мозга // Аллергология и иммунология. — 2005. — Т.6, №2. — С.278.
Чумаков В.А., Михайлов Р.В., Качков И.А. и др. Иммунодефицит, ассоциированный с глиобластомой // Аллергология и иммунология. — 2005. — Т.6, №2. — С.184.
Ярилин А.А., Никонова М.Ф., Ярилина А.А. и др. Апоптоз, роль в патологии и значимость его оценки при клинико-иммунологическом обследовании больных // Мед. иммунология. — 2000. — Т.2, №1. — С.7–16.
Bodey B., Bodey B.Jr., Siegel S.E., Kaiser H.E. Immunocytochemical detection of leukocyte-assotiated and apoptosis-related antigen expression in childhood brain tumors // Crit. Review Oncol. Hematol. — 2001. — V.39, N1–2. — P.3–16.
CD95-dependent T-cell killing by glioma cells expressing CD95 ligand: more on tumor immune escape, the CD95 counterattack, and the immune privilege of the brain // Intern. J. Experim. Cell. Physiol. Biochem. Pharmacol. — 2007. — V.7, N5. — P.282–288.
Choi C., Benveniste E.N. Fas ligand/Fas system in the brain: regulator of immune and apoptotic responses // Brain Res.Reviews. — 2004. — V.44, N1. — P.65–81.
Cohen N., Betts D.R., Tavori U. et al. Karyotypic evolution pathways in medulloblastoma/primitive neuroectodermal tumor determined with a combination of spectral karyotyping, G-banding, and fluorescence in situ hybridization // Cancer Gen. Cytogen. — 2004. — V.149, N1. — P.44–52.
Didenko V.V., Ngo H.N., Minchew C., Baskin D.S. Apoptosis of T-lymphocytes invading glioblastomas multiforme: a possible tumor defense mechanism // J. Neurosurg. — 2002. — V.96, N3. — P.580–584.
Dix A.R., Brooks W.H., Roszman T.L., Morford L.A. Immune defects observed in patients with primary malignant brain tumors // J. Neuroimmunol. — 1999. — V.100, N1–2. — P.216–232.
Eberhart C.G., Kaufman W.E., Tihan T., Burger P.C. Apoptosis, neuronal maturation, and neurotrophin expression within medulloblastoma nodules // J. Neuropathol. Exp. Neurol. — 2001. — V.60, N5. — P.462–469.
Frank A.J., Hernan R., Hollander A. et al. The TP53-ARF tumor suppressor pathway is frequently disrupted in large/cell anaplastic medulloblastoma // Molec. Brain Res. — 2004. — V.121, N1–2. — P.137–140.
Giordana M.T., Duo D., Gasverde S. et al. MDM2 overexpression is assotiated with short survival in adults with medulloblastoma // Neurooncology. — 2002. — V.4, N2. — P.115–122.
Kim J.Y.H., Nelson A.L., Algon S.A. et al. Medulloblastoma tumorigenesis diverges from cerebellar granule cell differentiation in patched heterozygous mice // Development. Biol. — 2003. — V.263, N1. — P.50–66.
Pingoud-Meier C., Lang D., Janss A.J. et al. Loss of caspase-8 protein expression correlates with unfavorable survival outcome in childhood medulloblastoma // Clin. Cancer Res. — 2003. — V.9, N17. — P.6401–6409.
Weller M., Schuster M., Pietsch T., Schabet M. CD95 ligand-induced apoptosis of human medulloblastoma cells // Cancer Lett. — 1998. — V.128, N2. — P.121–126.
Wischhusen J., Jung G., Radovanovic I. et al. Identification of CD70-mediated apoptosis of immune effector cells as a novel immune escape pathway of human glioblastoma // Cancer Res. — 2002. — V.62, N9. — P.2592–2599.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2009 N. I. Lisyany, L. D. Lyubych, А. Ya. Glavatsky, A. N. Lisyany
This work is licensed under a Creative Commons Attribution 4.0 International License.
Ukrainian Neurosurgical Journal abides by the CREATIVE COMMONS copyright rights and permissions for open access journals.
Authors, who are published in this Journal, agree to the following conditions:
1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the Journal under the terms of Creative Commons Attribution License, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this Journal.
2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form of which it has been published by the Journal (for example, to upload the work to the online storage of the Journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this Journal is included.
